Gene amplification of EGFR, HER2, HER3 and HER4 in esophageal squamous cell carcinoma

被引：0
|
作者：
Kato, Hiroaki [1 ]
Arao, Tokuzo [2 ]
Matsumoto, Kazuko [2 ]
Fujita, Yoshihiko [2 ]
Kimura, Hideharu [2 ]
Nishiki, Kouhei [1 ]
Shiraishi, Osamu [1 ]
Yasuda, Atsushi [1 ]
Peng, Ying-Feng [1 ]
Shinkai, Masayuki [1 ]
Imano, Motohiro [1 ]
Imamoto, Haruhiko [1 ]
Yasuda, Takushi [1 ]
Okuno, Kiyotaka [1 ]
Shiozaki, Hitoshi [1 ]
Nishio, Kazuto [2 ]
机构：
[1] Kinki Univ, Sch Med, Dept Surg, Osaka 589, Japan
[2] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4)
    Broughton, Marianne Nordlund
    Westgaard, Arne
    Paus, Elisabeth
    Oijordsbakken, Miriam
    Henanger, Karoline J.
    Naume, Bjorn
    Bjoro, Trine
    TUMOR BIOLOGY, 2017, 39 (06) : 1 - 11
  • [22] Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2
    Zhang, K
    Sun, JL
    Liu, NL
    Wen, DZ
    Chang, D
    Thomason, A
    Yoshinaga, SK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (07) : 3884 - 3890
  • [23] Novel agents that downregulate EGFR, HER2, and HER3 in parallel
    Ferreira, Renan Barroso
    Law, Mary Elizabeth
    Jahn, Stephan Christopher
    Davis, Bradley John
    Heldermon, Coy Don
    Reinhard, Mary
    Castellano, Ronald Keith
    Law, Brian Keith
    ONCOTARGET, 2015, 6 (12) : 10445 - 10459
  • [24] Simultaneous Expression of EGFR, HER2, HER3 and HER4 in Non-Small Cell Lung Cancer NSCLC: Correlation With Clinical Outcome and a Comparison Between Immunohistochemical Protein Expression and Silver In Situ Hybridization (SISH) For Detection of HER2 Gene Amplification
    Al-Saad, S.
    Al-Shibli, K.
    Donnem, T.
    Andersen, S.
    Bremnes, R. M.
    Busund, L. T.
    APMIS, 2010, 118 (03) : 245 - 246
  • [25] Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab
    Toru Kawamoto
    Kazunori Ishige
    Melanie Thomas
    Yoriko Yamashita-Kashima
    Sei Shu
    Nobuyuki Ishikura
    Shunichi Ariizumi
    Masakazu Yamamoto
    Kunihiko Kurosaki
    Junichi Shoda
    Journal of Gastroenterology, 2015, 50 : 467 - 479
  • [26] Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab
    Kawamoto, Toru
    Ishige, Kazunori
    Thomas, Melanie
    Yamashita-Kashima, Yoriko
    Shu, Sei
    Ishikura, Nobuyuki
    Ariizumi, Shunichi
    Yamamoto, Masakazu
    Kurosaki, Kunihiko
    Shoda, Junichi
    JOURNAL OF GASTROENTEROLOGY, 2015, 50 (04) : 467 - 479
  • [27] HER3 and HER4 are highly expressed in human meningiomas
    Arnli, Magnus Bossum
    Meta, Rahmina
    Lydersen, Stian
    Torp, Sverre Helge
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (10)
  • [28] Targeting HER3 and EGFR in NRG1 positive and HER3 mutated lung squamous cell carcinoma
    Pinzon-Ortiz, Maria C.
    Rong, Xianhui
    Versace, Richard
    Sheng, Qing
    Cao, Z. Alexander
    CANCER RESEARCH, 2015, 75
  • [29] HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
    Freeman, MR
    CANCER CELL, 2004, 6 (05) : 427 - 428
  • [30] Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Andersen, Rikke Fredslund
    Olsen, Dorte Aalund
    Jeppesen, Ulla
    Knudsen, Hans Jorgen
    Brandslund, Ivan
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 33 (01) : 195 - 204
12345